Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Anna Maria Berghella"'
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences immunological mechanisms in health and disease and identifying gender-specific biomarkers could
Externí odkaz:
https://doaj.org/article/e2fa33ad289a46f7ad59a019e6a293d2
Autor:
A. Aureli, Tiziana Del Beato, Angelica Canossi, P. Pellegrini, Enzo Secinaro, Anna Maria Berghella, Roberto Lattanzio, G. Marulli, Giancarlo Di Gregorio
Publikováno v:
Cancer Immunology ISBN: 9783030502867
Cancer Immunology Bench to Bedside Immunotherapy of Cancers, pp. 41–51, 2020
info:cnr-pdr/source/autori:Anna Maria Berghella, Anna Aureli,Angelica Canossi, Giuseppe Marulli,Roberto Lattanzio, Giancarlo Di Gregorio,Tiziana Del Beato, Enzo Secinaro,and Patrizia Pellegrini/titolo:Personalized Prevention Strategies to Defeat Cancer/titolo_volume:Cancer Immunology Bench to Bedside Immunotherapy of Cancers/curatori_volume:/editore:/anno:2020
Cancer Immunology Bench to Bedside Immunotherapy of Cancers, pp. 41–51, 2020
info:cnr-pdr/source/autori:Anna Maria Berghella, Anna Aureli,Angelica Canossi, Giuseppe Marulli,Roberto Lattanzio, Giancarlo Di Gregorio,Tiziana Del Beato, Enzo Secinaro,and Patrizia Pellegrini/titolo:Personalized Prevention Strategies to Defeat Cancer/titolo_volume:Cancer Immunology Bench to Bedside Immunotherapy of Cancers/curatori_volume:/editore:/anno:2020
The mortality of cancer patients is still high, especially for some types, such as the colorectal cancer (CRC). A large amount of scientific data is available to improve management of these diseases. Cancer treatments are not effective in all patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a452af810edfedf4111a1563ba340a17
https://doi.org/10.1007/978-3-030-50287-4_3
https://doi.org/10.1007/978-3-030-50287-4_3
Autor:
Tiziana Del Beato, Luigi Liborio Liberatore, Ida Contasta, Anna Maria Berghella, Antonio Mongelli, Enzo Secinaro, Irma Campitelli, Giancarlo Di Gregorio, Matteo Basta, Fabiana Ciccone, Mauro Domenicucci, Patrizia Pellegrini, Roberto Lattanzio, Nunzia Antonucci, Vincenzo Vittorini, Luca Navarra, Giampaolo Caterino, Marino Silvino
Publikováno v:
Current drug targets
18 (2017): 485–495. doi:10.2174/1389450117666160630173647
info:cnr-pdr/source/autori:Berghella, Anna Maria; Contasta, Ida; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore, Luigi Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; and Pellegrini, Patrizia/titolo:The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy/doi:10.2174%2F1389450117666160630173647/rivista:Current drug targets (Print)/anno:2017/pagina_da:485/pagina_a:495/intervallo_pagine:485–495/volume:18
18 (2017): 485–495. doi:10.2174/1389450117666160630173647
info:cnr-pdr/source/autori:Berghella, Anna Maria; Contasta, Ida; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore, Luigi Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; and Pellegrini, Patrizia/titolo:The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy/doi:10.2174%2F1389450117666160630173647/rivista:Current drug targets (Print)/anno:2017/pagina_da:485/pagina_a:495/intervallo_pagine:485–495/volume:18
The definition of personalized treatments in tumor disease could lead to an improvement of the therapeutic success rate. Therefore, biomarkers are urgently required in order to select the patients that could benefit from adjuvant therapies in the ini
Autor:
Tiziana Del Beato, A. Aureli, Alessia Colanardi, Angelica Canossi, Patrizia Pellegrini, Anna Maria Berghella
Publikováno v:
World journal of gastrointestinal oncology 11 (2019): 117–138. doi:10.4251/wjgo.v11.i2.117
info:cnr-pdr/source/autori:Anna Maria Berghella, Anna Aureli, Angelica Canossi, Tiziana Del Beato, Alessia Colanardi, Patrizia Pellegrini/titolo:Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer/doi:10.4251%2Fwjgo.v11.i2.117/rivista:World journal of gastrointestinal oncology/anno:2019/pagina_da:117/pagina_a:138/intervallo_pagine:117–138/volume:11
World Journal of Gastrointestinal Oncology
info:cnr-pdr/source/autori:Anna Maria Berghella, Anna Aureli, Angelica Canossi, Tiziana Del Beato, Alessia Colanardi, Patrizia Pellegrini/titolo:Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer/doi:10.4251%2Fwjgo.v11.i2.117/rivista:World journal of gastrointestinal oncology/anno:2019/pagina_da:117/pagina_a:138/intervallo_pagine:117–138/volume:11
World Journal of Gastrointestinal Oncology
BACKGROUND Identifying biomarkers for the risk of developing degenerative processes linked to aging and colorectal cancer (CRC) onset that could improve clinical strategies. AIM To determine valid targets and a predictive biomarker's system of chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da76b26c6dd7805da48dadf1df8c887b
https://www.wjgnet.com/1948-5204/full/v11/i2/117.htm
https://www.wjgnet.com/1948-5204/full/v11/i2/117.htm
Autor:
Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo, Francesca Gizzi, Marco Bartolomucci, Giacomo Laglia, Marisa Valeri, Mario Gizzi, Mauro Friscioni, Mario Barone, Tiziana Del Beato, Enzo Secinaro, Patrizia Pellegrini
Publikováno v:
Immunity & ageing (2016). doi:10.1186/1742-4933-11-3
info:cnr-pdr/source/autori:Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo, Francesca Gizzi, Marco Bartolomucci, Giacomo Laglia, Marisa Valeri, Mario Gizzi, Mauro Friscioni, Mario Barone, Tiziana Del Beato, Enzo Secinaro and Patrizia Pellegrini/titolo:Day of Immunology 2015/doi:10.1186%2F1742-4933-11-3/rivista:Immunity & ageing/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo, Francesca Gizzi, Marco Bartolomucci, Giacomo Laglia, Marisa Valeri, Mario Gizzi, Mauro Friscioni, Mario Barone, Tiziana Del Beato, Enzo Secinaro and Patrizia Pellegrini/titolo:Day of Immunology 2015/doi:10.1186%2F1742-4933-11-3/rivista:Immunity & ageing/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
Low-grade inflammatory state causes the development of the principal chronic-degenerative pathologies related with ageing. Consequently, it is required a better comprehension of the physiologic origins and the consequences of the low-grade inflammato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::385d8666111d57818bf4e4d7184f322f
Publikováno v:
Cancer Immunology, Immunotherapy
Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical practice. It is hoped that the move from generalized to stratified approaches, with the grouping
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Clinical and Developmental Immunology
Clinical & developmental immunology
1 (2011): 16.
info:cnr-pdr/source/autori:Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, and Anna Maria Berghella./titolo:Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer./doi:/rivista:Clinical & developmental immunology (Print)/anno:2011/pagina_da:16/pagina_a:/intervallo_pagine:16/volume:1
Clinical and Developmental Immunology
Clinical & developmental immunology
1 (2011): 16.
info:cnr-pdr/source/autori:Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, and Anna Maria Berghella./titolo:Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer./doi:/rivista:Clinical & developmental immunology (Print)/anno:2011/pagina_da:16/pagina_a:/intervallo_pagine:16/volume:1
Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences immunological mechanisms in health and disease and identifying gender-specific biomarkers could
Publikováno v:
Transplant Immunology. 12:49-61
Understanding the physiological role of CD30 would be an important step forward in transplants because CD30+ T cells can be induced by alloantigens even in the presence of immunosuppressives such as cyclosporine (Csa) and hence can act as regulatory
Autor:
Antonio Mongelli, Giampaolo Caterino, Maurizio Vizioli, Osvaldo Ciccarelli, Ida Contasta, P. Pellegrini, Enzo Secinaro, Marino Silvino, Tiziana Del Beato, Roberto Lattanzio, Luca Navarra, Luigi Liborio Liberatore, Irma Campitelli, Giancarlo Di Gregorio, Anna Maria Berghella, Nunzia Antonucci, Vincenzo Vittorini
Publikováno v:
Cancer Immunology ISBN: 9783662449455
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, edited by Nima Rezaei, pp. 35–54. Berlin Heidelberg: Springer, 2015
info:cnr-pdr/source/autori:CONTASTA IDA 2, BERGHELLA ANNA MARIA 2, LATTANZIO ROBERTO 3, CICCARELLI OSVALDO 3, DI GREGORIO GIANCARLO 4, VIZIOLI MAURIZIO 5, SILVINO MARINO 6, LIBERATORE LUIGI LIBORIO 3, NAVARRA LUCA 3, CATERINO GIAMPAOL 3, MONGELLI ANTONIO 3, VITTORINI VINCENZO 3, CAMPITELLI IRMA 4, NUNZIA ANTONUCCI 3, DEL BEATO TIZIANA 2, SECINARO ENZO 7 AND PELLEGRINI PATRIZIA 2/titolo:Novel Prognostic Biomarkers for Personalized Cancer Treatment/titolo_volume:Cancer Immunology: Bench to Bedside Immunotherapy of Cancers/curatori_volume:Nima Rezaei/editore: /anno:2015
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, edited by Nima Rezaei, pp. 35–54. Berlin Heidelberg: Springer, 2015
info:cnr-pdr/source/autori:CONTASTA IDA 2, BERGHELLA ANNA MARIA 2, LATTANZIO ROBERTO 3, CICCARELLI OSVALDO 3, DI GREGORIO GIANCARLO 4, VIZIOLI MAURIZIO 5, SILVINO MARINO 6, LIBERATORE LUIGI LIBORIO 3, NAVARRA LUCA 3, CATERINO GIAMPAOL 3, MONGELLI ANTONIO 3, VITTORINI VINCENZO 3, CAMPITELLI IRMA 4, NUNZIA ANTONUCCI 3, DEL BEATO TIZIANA 2, SECINARO ENZO 7 AND PELLEGRINI PATRIZIA 2/titolo:Novel Prognostic Biomarkers for Personalized Cancer Treatment/titolo_volume:Cancer Immunology: Bench to Bedside Immunotherapy of Cancers/curatori_volume:Nima Rezaei/editore: /anno:2015
Neoplastic pathologies are one of the most frequent cause of death in the world and, in spite of the treatment's improvement, the related mortality of tumour is high. One of the principal cause of this situation is the lack of clinical prognostic bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9788b660b8efef7249b00af1b61ea8e9
https://doi.org/10.1007/978-3-662-44946-2_3
https://doi.org/10.1007/978-3-662-44946-2_3
Publikováno v:
Cancer biotherapy & radiopharmaceuticals 16 (2001): 63–71.
info:cnr-pdr/source/autori:Contasta I., Pellegrini P., Berghella AM., Adorno D./titolo:Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules/doi:/rivista:Cancer biotherapy & radiopharmaceuticals/anno:2001/pagina_da:63/pagina_a:71/intervallo_pagine:63–71/volume:16
info:cnr-pdr/source/autori:Contasta I., Pellegrini P., Berghella AM., Adorno D./titolo:Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules/doi:/rivista:Cancer biotherapy & radiopharmaceuticals/anno:2001/pagina_da:63/pagina_a:71/intervallo_pagine:63–71/volume:16
Cytokine regulation of lymphocyte survival may play an important role in the control of the cell cycle during the immune response both in health and disease. Expression of the Bcl2 gene promotes cell survival by countering apoptosis stimuli. The p53